Andersen, Christen L <br/><br/>
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis.  [electronic resource] 

 -  Haematologica  Jan 2014 
 - e5-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Letter 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2013.096669  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Hydroxamic Acids--therapeutic use<br/>Polycythemia Vera--complications<br/>Primary Myelofibrosis--complications<br/>Treatment Outcome<br/>Vorinostat